Post Translational Medicines
PrivateLast Round
Accelerator
Jul 1, 2025
Total Funding Raised
$200,000
Company Overview
Post Translational Medicines operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in July 2025.
Post Translational Medicines is a biotechnology company that develops proteomics-based therapeutics and drug discovery platforms targeting the 'Dark Proteome' to address neurodegeneration and aging-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Post Translational Medicines Comparables
Compare Post Translational Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protai | 84% | |
| Topos Bio | 84% | |
| ProQomics | 81% |
For institutional investors. Book with your work email.
Post Translational Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2025 | ||||
| Pre Seed | Jun 27, 2025 |
For institutional investors. Book with your work email.
Post Translational Medicines Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
Secured funding from SOSV and IndieBio.
- Jun 27, 2025
$200K round with Antler participating.
For institutional investors. Book with your work email.
Post Translational Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Post Translational Medicines's valuation, stock price, and market status.
Is Post Translational Medicines a public or private company?
Post Translational Medicines is a private company.
What is the current stock price of Post Translational Medicines?
Post Translational Medicines is a private company, so its shares have no public market price. Caplight tracks Post Translational Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Post Translational Medicines worth (valuation)?
Valuation information for Post Translational Medicines is not publicly available.
Can I buy Post Translational Medicines stock?
Post Translational Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Post Translational Medicines's last funding round?
Post Translational Medicines's most recent funding round was Accelerator on July 1, 2025.
Who are the main investors in Post Translational Medicines?
Key investors in Post Translational Medicines include IndieBio, Antler, SOSV.
Will Post Translational Medicines IPO soon?
No public IPO plans have been announced for Post Translational Medicines.
How can I track Post Translational Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Post Translational Medicines's shares on secondary markets.